|
|
||||||||
The Journal of Immunology, Vol 142, Issue 8 2583-2589, Copyright © 1989 by American Association of Immunologists
ARTICLES |
R Gerli, A Bertotto, S Crupi, C Arcangeli, I Marinelli, F Spinozzi, C Cernetti, P Angelella and P Rambotti
Department of Internal Medicine, University of Perugia, Italy.
A study was carried out on cord blood T cell activation via the CD2- mediated pathway. Despite similar percentages of circulating CD3+ and CD2+ cells in adult and cord blood, the proliferation of cord PBMC to the anti-CD3 mAb and cord T cells to anti-CD2 mAb were defective. The T cell CD3-surface structure was normally able to control CD2-mediated activation, as its modulation by a non-mitogenic anti-CD3 mAb blocked cord PBMC proliferation induced by anti-CD2 mAb. CD2-stimulated cord T cells did not proliferate and did not produce a significant amount of IL-2 in culture, although they expressed the IL-2R. This observation was confirmed by the optimal proliferation of CD2-induced cord T cells when rIL-2 was added. Despite the alternative T cell activation pathway is monocyte-independent in adults, the defective cord T cell activation via the CD2 molecule could also be bypassed by the addition of PMA, small amounts of either autologous or allogeneic adult and cord AC or simply rIL-1 alone. Our findings provide evidence for an intrinsic functional defect in cord CD2-mediated T cell activation, which is linked to an impaired increase of free cytoplasmic calcium, as confirmed by the effectiveness of calcium ionophore A23187 in restoring a good CD2-induced cord T cell proliferation and by measurement of cellular calcium uptake after activation via the CD2 molecule. The characteristics of cord T cells revealed by this study recall the thymocyte functional pattern and may represent functional expression of the previously described phenotypic immaturity of cord T cells.
This article has been cited by other articles:
![]() |
M. R. Goldberg, N. Luknar-Gabor, G. Zadik-Mnuhin, P. Koch, J. Tovbin, and Y. Katz Synergy between LPS and immobilized anti-human CD3{epsilon} mAb for activation of cord blood CD3+ T cells Int. Immunol., January 1, 2007; 19(1): 99 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canto, J. L. Rodriguez-Sanchez, and S. Vidal Distinctive response of naive lymphocytes from cord blood to primary activation via TCR J. Leukoc. Biol., December 1, 2003; 74(6): 998 - 1007. [Abstract] [Full Text] |
||||
![]() |
V. de La Selle, E. Gluckman, and M. Bruley-Rosset Graft-Versus-Host Disease and Graft-Versus-Leukemia Effect in Mice Grafted With Peripheral Newborn Blood Blood, November 15, 1998; 92(10): 3968 - 3975. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |